Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  HIV Infection

  Free Subscription


Articles published in J Clin Invest

Retrieve available abstracts of 21 articles:
HTML format



Single Articles


    August 2022
  1. FOX DA
    Immunodeficiency and autoimmunity: companions not opposites.
    J Clin Invest. 2022;132.
    PubMed     Abstract available


    July 2022
  2. GRUDDA T, Hwang HS, Taddese M, Quinn J, et al
    Integrated hepatitis B virus DNA maintains surface antigen production during antivirals.
    J Clin Invest. 2022 Jul 7. pii: 161818. doi: 10.1172/JCI161818.
    PubMed     Abstract available


    June 2022
  3. TAKATA H, Trautmann L
    Transforming dysfunctional CD8+ T cells into natural controller-like CD8+ T cells: can TCF-1 be the magic wand?
    J Clin Invest. 2022;132.
    PubMed     Abstract available


    May 2022
  4. BALLE C, Armistead B, Kiravu A, Song X, et al
    Factors influencing maternal microchimerism throughout infancy and its impact on infant T cell immunity.
    J Clin Invest. 2022 May 12. pii: 148826. doi: 10.1172/JCI148826.
    PubMed     Abstract available


    April 2022
  5. FALCINELLI SD, Peterson JJ, Turner AW, Irlbeck D, et al
    Combined noncanonical NF-kappaB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo.
    J Clin Invest. 2022;132.
    PubMed     Abstract available


  6. PERDOMO-CELIS F, Passaes C, Monceaux V, Volant S, et al
    Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control.
    J Clin Invest. 2022 Apr 5. pii: 157549. doi: 10.1172/JCI157549.
    PubMed     Abstract available


  7. LEYRE L, Jones RB
    Hide and seek: for HIV-infected CD4+ T cells, playing well comes with maturity.
    J Clin Invest. 2022;132:1-4.
    PubMed     Abstract available


    March 2022
  8. VARCO-MERTH BD, Brantley W, Marenco A, Duell DD, et al
    Rapamycin limits CD4+ T cell proliferation in simian immunodeficiency virus-infected rhesus macaques on antiretroviral therapy.
    J Clin Invest. 2022 Mar 22. pii: 156063. doi: 10.1172/JCI156063.
    PubMed     Abstract available


  9. FERRARI B, Da Silva AC, Liu KH, Saidakova EV, et al
    Gut-derived bacterial toxins impair memory CD4 T-cell mitochondrialfunction in HIV-1infection.
    J Clin Invest. 2022 Mar 22. pii: 149571. doi: 10.1172/JCI149571.
    PubMed     Abstract available


  10. HARPER J, Ribeiro SP, Chan CN, Aid M, et al
    Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy.
    J Clin Invest. 2022 Mar 1. pii: 155251. doi: 10.1172/JCI155251.
    PubMed     Abstract available


    February 2022
  11. DUETTE G, Hiener B, Morgan H, Mazur FG, et al
    The HIV-1 proviral landscape reveals Nef contributes to HIV-1 persistence in effector memory CD4+ T-cells.
    J Clin Invest. 2022 Feb 8. pii: 154422. doi: 10.1172/JCI154422.
    PubMed     Abstract available


  12. ARMSTRONG E, Hemmerling A, Miller S, Burke KE, et al
    Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis-associated bacteria rather than lactobacilli.
    J Clin Invest. 2022 Feb 3. pii: 152930. doi: 10.1172/JCI152930.
    PubMed     Abstract available


    December 2021
  13. SHARAN R, Ganatra SR, Bucsan AN, Cole J, et al
    Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a tuberculosis/simian immunodeficiency virus coinfection model.
    J Clin Invest. 2021 Dec 2. pii: 153090. doi: 10.1172/JCI153090.
    PubMed     Abstract available


  14. CAMPION SL, Brenna E, Thomson E, Fischer W, et al
    Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


    November 2021
  15. SCULLY EP, Bryson BD
    Unlocking the complexity of HIV and Mycobacterium tuberculosis coinfection.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


  16. MITCHELL JL, Pollara J, Dietze K, Edwards RW, et al
    Anti-HIV antibody development up to one year after antiretroviral therapy initiation in acute HIV infection.
    J Clin Invest. 2021 Nov 11. pii: 150937. doi: 10.1172/JCI150937.
    PubMed     Abstract available


    October 2021
  17. LI M, Garforth SJ, O'Connor KE, Su H, et al
    T-cell receptor-specific immunotherapeutics drive selective in vivo HIV and CMV-specific T-cell expansion in humanized mice.
    J Clin Invest. 2021 Oct 21. pii: 141051. doi: 10.1172/JCI141051.
    PubMed     Abstract available


  18. PETERSON CW
    HIV-specific CAR T cells return to the clinic.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


    September 2021
  19. QUINN TC
    Forty years of AIDS: a retrospective and the way forward.
    J Clin Invest. 2021;131.
    PubMed    


  20. DIAS J, Fabozzi G, March K, Asokan M, et al
    Concordance of immunological events between intrarectal and intravenous SHIVAD8-EO infection when assessed by Fiebig-equivalent staging.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


    August 2021
  21. MENDEZ-LAGARES G, Chin N, Chang WLW, Lee J, et al
    Cytomegalovirus mediates expansion of IL-15-responsive innate-memory cells with SIV killing function.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: